Last reviewed · How we verify

NCT04682756

A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model

Status unknown Last updated 31 December 2020
What this trial tests

trial testing The model of machine learning in NSTEMI - Non-ST Segment Elevation MI in 2,500 participants. Status unknown.

Timeline
20 December 2020
Primary endpoint
20 December 2021
1 June 2022

Quick facts

Lead sponsorFirst Affiliated Hospital of Xinjiang Medical University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,500
Start date20 December 2020
Primary completion20 December 2021
Estimated completion1 June 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

First Affiliated Hospital of Xinjiang Medical University

Who can join

Adults 18 to 75, any sex, with NSTEMI - Non-ST Segment Elevation MI or Unstable Angina. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early diagnosis of NSTEMI and UA patients is mainly through the construction of machine learning model.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for NSTEMI - Non-ST Segment Elevation MI

Currently open trials in the same condition.

Other First Affiliated Hospital of Xinjiang Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04682756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing